Publications (56) Publications in which a researcher has participated

2006

  1. Automated user modeling for personalized digital libraries

    International Journal of Information Management, Vol. 26, Núm. 3, pp. 234-248

  2. Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?

    Clinical and Vaccine Immunology, Vol. 13, Núm. 1, pp. 160-161

  3. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges

    Journal of Infectious Diseases, Vol. 194, Núm. 7, pp. 904-911

  4. Chronic hepatitis C in HIV-infected patients: Those who more need therapy are those who respond less

    Infectious Disorders - Drug Targets, Vol. 6, Núm. 1, pp. 57-68

  5. Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients

    Clinical Infectious Diseases, Vol. 43, Núm. 9, pp. 1209-1212

  6. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection

    AIDS, Vol. 20, Núm. 15, pp. 1951-1954

  7. Critical facilities for active participation in learning networks

    International Journal of Web Based Communities, Vol. 2, Núm. 1, pp. 81-99

  8. Dirección por misiones: primeras experiencias de éxito

    Economistas, Año 24, Núm. 109, pp. 101-107

  9. Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent

    Antimicrobial Agents and Chemotherapy, Vol. 50, Núm. 2, pp. 694-701

  10. Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: Results from a large multicenter observational cohort

    Journal of Acquired Immune Deficiency Syndromes, Vol. 41, Núm. 2, pp. 154-159

  11. Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes

    AIDS Reviews, Vol. 8, Núm. 2, pp. 98-107

  12. Entrada del virus de la inmunodeficiencia humana en las células: Mecanismos y posibilidades terapéuticas

    Medicina Clinica, Vol. 126, Núm. 9, pp. 341-348

  13. Evaluación de competencias comunicativas para la comprensión de emociones, afectos e intenciones en personal con diferentes cuadros clínicos

    Ansiedad y estrés, Vol. 12, Núm. 2, pp. 365-377

  14. Gene polymorphisms, isoenzyme activity, and emergence of resistance to efavirenz

    Contagion: Reports, Cases, and Commentaries in HIV and Infectious Disease Research, Vol. 3, Núm. 1, pp. 18-22

  15. HIV and HCV coinfection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 5, pp. 335-346

  16. HIV entry inhibitors: Mechanisms of action and resistance pathways

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 4, pp. 619-627

  17. HIV tropism: Diagnostic tools and implications for disease progression and treatment with entry inhibitors

    AIDS, Vol. 20, Núm. 10, pp. 1359-1367

  18. HTLV infection among young injection and non-injection heroin users in Spain: Prevalence and correlates

    Journal of Clinical Virology, Vol. 35, Núm. 3, pp. 244-249

  19. High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART

    AIDS, Vol. 20, Núm. 1, pp. 127-129

  20. Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir

    AIDS Research and Human Retroviruses, Vol. 22, Núm. 4, pp. 333-337